Beacon Pharmaceuticals

85 High Street, Tunbridge Wells, TN1 1YG
Telephone: +44 (0)1892 600 930
Fax: +44 (0)1892 600 937
WWW: http://www.beaconpharma.co.uk
Medical Information e-mail: info@beaconpharma.co.uk

Patient Information Leaflet last updated on the eMC: 18/10/2010
PIL Ranitidine 50mg/2ml Solution for Injection and Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/10/2010 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 22/09/2010 and displayed until 18/10/2010
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to how the medicine works
  • Change of contra-indications
  • Change to side-effects
Updated on 17/12/2009 and displayed until 22/09/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to information for healthcare professionals
Updated on 14/10/2009 and displayed until 17/12/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ranitidine hydrochloride